Craft

Virax Biolabs

Stock Price

$2.2

2024-10-29

Market Capitalization

$9.5 M

2024-10-29

Revenue

$6 K

FY, 2025

Virax Biolabs Summary

Company Summary

Overview
Virax Biolabs Group is a biotechnology company that sells, distributes, and markets diagnostics test kits and med-tech and PPE (personal protective equipment) products for the prevention, detection, diagnosis, and risk management of viral diseases with a focus on immunology. It offers diagnostics test kits through the ViraxCare brand, med-tech and PPE products through the ViraxClear brand, and an immunology profiling platform through the Virax Immune brand.
Type
Public
Status
Active
Founded
2013
HQ
London, GB | view all locations
Website
https://www.viraxbiolabs.com/
Cybersecurity rating
Sectors

Key People

  • James Foster

    James Foster, Chief Executive Officer

  • Mark Ternouth

    Mark Ternouth, Chief Technical Officer

  • Jason Davis

    Jason Davis, Chief Financial Officer

  • Yair Erez

    Yair Erez, Independent Director

    LocationsView all

    4 locations detected

    • London, England HQ

      United Kingdom

      30 Broadwick St

    • Shanghai, Shang Hai Shi

      China

      1515 Nanjing West Road

    • Hong Kong, Hong Kong Island

      Hong Kong

      Unit 1405, 14/F. Tower 1, Admiralty Centre, 18 Harcourt Road

    • Singapore

      Singapore

      531A Upper Cross St, #04-98

    Virax Biolabs Financials

    Summary Financials

    Revenue (H1, 2026)
    $2.0K
    Gross profit (H1, 2026)
    $2.0K
    Net income (H1, 2026)
    ($2.3M)
    Cash (H1, 2026)
    $3.3M
    EBIT (H1, 2026)
    ($2.6M)
    Enterprise value
    $6.3M

    Footer menu